VEGF gene polymorphism association with diabetic neuropathy
- 30 March 2010
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 37 (7) , 3625-3630
Abstract
Vascular factors beside metabolic problems are involved in both etiopathogenesis of diabetic neuropathy, and more remarkably, later in “repair” phase, that governs the net balance between neuro-regenerative/degenerative reactions. Regarding ischemic nature of diabetic neuropathy that highlights necessity of blood vessels re-establishment during tissue healing, VEGF (vascular endothelial growth factor) has been recently the subject of extensive investigations in diabetic neuropathy (DNU). This growth factor possesses angiogenic potentials in addition to the hemodynamic functions. The distribution of VEGF gene polymorphisms at positions −7*C/T, −1001*G/C, −1154*G/A and −2578*C/A were analysed by ARMS–PCR in 248 type 1 diabetic British-Caucasian subjects (81 DNU+, 167 DNU−). We have found that distribution of a VEGF gene polymorphism at promoter region (−7*C/T) was significantly different between diabetic subjects with vs. without neuropathy and the allele (C) conferred susceptibility to DNU (P = 0.02; OR = 1.78, 95% CI 1.0–3.1). The present study indicates that polymorphism of the VEGF gene at position −7*C/T might be implicated in the pathogenesis of diabetic neuropathy as it may harbour some functional/regulatory potential in VEGF gene expression. However, this requires further studies in order to better understand its phenotypic impact and to investigate the prognostic value of this polymorphism in diabetic neuropathy as a chronic complication of diabetes.Keywords
This publication has 44 references indexed in Scilit:
- Diabetic vascular dysfunction: Links to glucose‐induced reductive stress and VEGFMicroscopy Research and Technique, 2002
- Vascular Dysfunction Induced by AGE is Mediated by VEGF via Mechanisms Involving Reactive Oxygen Species, Guanylate Cyclase, and Protein Kinase CMicrocirculation, 2001
- Reversal of experimental diabetic neuropathy by VEGF gene transferJournal of Clinical Investigation, 2001
- IDENTIFICATION OF POLYMORPHISMS WITHIN THE VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) GENE: CORRELATION WITH VARIATION IN VEGF PROTEIN PRODUCTIONCytokine, 2000
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5' end of the aldose reductase geneJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor.Journal of Clinical Investigation, 1997
- Heterozygous embryonic lethality induced by targeted inactivation of the VEGF geneNature, 1996
- The Aetiology of Diabetic Neuropathy: the Combined Roles of Metabolic and Vascular DefectsDiabetic Medicine, 1995
- Familial Clustering of Diabetic Kidney DiseaseNew England Journal of Medicine, 1989